LUNG today
$2.86-$0.14 (-4.67%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourDescending Triangle
1 hourStrong Bearish
15 minSymmetric Triangle
5 minExpanding
Daily trend turns down below $1.13
Key levels
Resistance$3.17
Resistance$2.89
Support$2.48
Support$2.09
Latest news & SEC filings
AnalystStifel keeps Buy rating on Pulmonx, lifts target to $4
All LUNG news →About Pulmonx
Pulmonx is a medical technology company that treats severe emphysema, a form of COPD, with a minimally invasive approach. Its main product is the Zephyr Endobronchial Valve, a one-way valve implanted in the lungs, along with the Chartis Pulmonary Assessment System for measuring collateral ventilation and the LungTraX Platform for CT-based patient selection. The company sells to pulmonologists and hospitals in the United States and internationally, using direct sales in most markets and distributors elsewhere.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
Pulmonx Corp (LUNG)
What Is the Price Target for LUNG?
SEPT Low Target
$4.00
SEPT Mid Target
$4.00
SEPT High Target
$4.00
Analyst Consensus
$4.00
Is LUNG a Buy or Sell Right Now?
Thesis
- •Revenue growing 8.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LUNG.
Start Free Trial →Is LUNG Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$3.58
35
Moat Score
NONE
3/9
Piotroski Score
-4.6
Altman Z-Score
What Is Smart Money Doing with LUNG?
Insider Signal
SELLING
0 buys / 14 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ferrari Richard | director | Buy | 40,000 | - | Jun 5, 2026 |
| Sullivan Tiffany | director | Buy | 40,000 | - | Jun 5, 2026 |
| Melenikiotou Georgia | director | Buy | 40,000 | - | Jun 5, 2026 |
| Burns Thomas William | director | Buy | 40,000 | - | Jun 5, 2026 |
| Florin Daniel P | director | Buy | 40,000 | - | Jun 5, 2026 |
| Mead Dana G Jr. | director | Buy | 40,000 | - | Jun 5, 2026 |
| French Glendon E. III | director officer | Sale | 13,511 | $21K | Jun 2, 2026 |
| Radhakrishnan Srikanth | officer | Sale | 2,691 | $4K | Jun 1, 2026 |
| Radhakrishnan Srikanth | officer | Sale | 2,153 | $3K | Jun 1, 2026 |
| Radhakrishnan Srikanth | officer | Sale | 3,684 | $6K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LUNG Growth Story
Revenue YoY
8.0%
3yr Revenue CAGR
19.0%
EPS Growth YoY
7.64%
FCF Growth YoY
0.5%
Revenue Trend
STRONG
Dark Pool Trades for LUNG
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LUNG, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:45:05 | $2.92 | 1,022 | $$3K | MIDPOINT |
| 20:32:31 | $2.90 | 1,500 | $$4K | SELL |
| 20:28:59 | $2.90 | 1,289 | $$4K | BUY |
| 20:28:42 | $2.90 | 2,800 | $$8K | BUY |
| 20:05:05 | $2.92 | 1,238 | $$4K | BUY |
5 dark pool trades shown · $$23K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Pulmonx Corp (LUNG) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LUNG — frequently asked questions
What is LUNG stock price today?
Pulmonx Corp (LUNG) is at $2.86, down 4.67% (-$0.14) at the Nov 13, 2026 close.
Why is LUNG stock moving today?
Latest LUNG news — Oct 28, 2026: Stifel keeps Buy rating on Pulmonx, lifts target to $4
What is the LUNG price target?
The average analyst price target for LUNG is $4.00, ranging from $4 to $4, based on 1 analysts. Latest: Stifel maintains on Oct 28, 2026.
What do analysts rate LUNG?
Analyst ratings for LUNG: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did LUNG beat earnings?
LUNG last reported on Oct 27, 2026: EPS -$0.19 vs -$0.26 expected — a beat of 26.0%.
Does LUNG pay a dividend?
LUNG does not currently pay a dividend.
How much debt does LUNG have?
Pulmonx Corp reported $38M of debt and $56M of cash (Jun 30, 2026).
What are LUNG support and resistance levels?
Support: $2.48, $2.09, $1.75. Resistance: $2.89, $3.17, $3.56.
What are insiders doing with LUNG?
Insider activity: SELLING, 0 buys and 14 sells in the last 90 days.
What is the latest news on LUNG?
Oct 28, 2026: Stifel keeps Buy rating on Pulmonx, lifts target to $4